Calpain S-1 (Recombinant)

Recombinant Protein · expressed in HEK293
Citation tracking pending
Recombinant human Calpain small subunit 1 (CAPNS1; UniProt P04632), expressed in HEK293 cells. Regulatory subunit of the calcium-dependent calpain holoenzyme; suited for reconstitution assays, inhibitor profiling, and antibody validation.
Expression system
HEK293
Cat. #
REC-CalpainS1

In stock

SKU
REC-CalpainS1
$498.00

Target Overview

Calpain small subunit 1 (CAPNS1; UniProt P04632) is the 268-amino-acid regulatory subunit shared by the ubiquitously expressed calpain-1 (µ-calpain) and calpain-2 (m-calpain) heterodimers. The subunit contains a penta-EF-hand domain (domain V) that coordinates calcium binding and is required for holoenzyme stability and membrane association; without it, the catalytic large subunit is rapidly degraded in vivo. This recombinant is produced in HEK293 cells, providing mammalian post-translational processing and folding that preserves the calcium-sensing EF-hand architecture relevant to functional studies. In the research setting, recombinant CAPNS1 is used primarily in two contexts. First, it enables reconstitution of active calpain heterodimers in vitro: when co-expressed or co-incubated with a recombinant calpain large subunit (CAPN1 or CAPN2), the small subunit is required to form a protease-competent complex, making it an essential component of substrate-cleavage and inhibitor-screening assays. Second, the full-length recombinant protein (residues 1–268) serves as a well-defined positive control antigen for antibody validation by Western blot and dot blot, confirming band identity at the expected molecular weight and enabling titration of detection reagents. Researchers investigating calcium-dependent proteolysis in cardiac, neuronal, and pancreatic cell models routinely use recombinant CAPNS1 alongside matched antibodies to confirm target engagement. Pairs with the Triple Point Biologics matched antibody (SKU: RP-CalpainS1) for side-by-side validation workflows.

Background

The calpain family comprises calcium-regulated, non-lysosomal cysteine proteases that perform limited, regulatory proteolysis of a broad range of cytoskeletal, signalling, and mitochondrial substrates. Calpain small subunit 1 (CAPNS1) is the common regulatory subunit of the two ubiquitous isoforms, calpain-1 and calpain-2, and is essential for their intracellular stability and activity. Genetic ablation of CAPNS1 in mice is embryonically lethal, underscoring its non-redundant role in development. In basic research, the calpain system has been extensively characterised in the context of ischemia-reperfusion injury. Calcium overload during ischemia-reperfusion activates calpains, which then cleave mitochondrial respiratory chain components and structural proteins. Li et al. (2022) performed proteomic profiling of calpain-mediated substrates in cardiac mitochondria following ischemia-reperfusion, identifying multiple complex I and complex III subunits as cleavage targets — work that depends on well-defined recombinant calpain components for biochemical validation (PMID: 34997008). Related studies have investigated how endoplasmic reticulum (ER) stress triggers calcium release that activates calpains, leading to respiratory chain dysfunction; both Chen et al. (2024) and Mohsin et al. (2020) used calpain inhibitor and activity paradigms in which a recombinant small subunit is a useful reference reagent for verifying antibody specificity and enzyme reconstitution fidelity. Beyond cardiac models, calpain activity has been characterised in pancreatic tissue. A proteome study of pig pancreatic islets and exocrine tissue by Nakashima et al. (2017) identified CAPNS1 among the proteins detected by LC-MS/MS, pointing to a role for calpain-mediated proteolysis in islet biology and illustrating the protein's presence across secretory tissues. CAPNS1 has also appeared in proteomic resistance profiling of myeloma cell lines (Jian et al., 2016), reflecting the broader interest in calpain-dependent pathways across cell-death and survival research. For researchers designing inhibitor screens, the small subunit is a necessary component of any reconstituted calpain assay: inhibitor IC50 values measured against isolated large subunit alone do not reflect holoenzyme kinetics. Recombinant CAPNS1 expressed in HEK293 cells provides a mammalian-folded, calcium-competent regulatory subunit for these reconstitution experiments. It is equally useful as an immunoblot standard when paired with the Triple Point Biologics matched antibody (RP-CalpainS1), which has been validated for Western blot across more than three decades of proteinase/inhibitor antibody development at Triple Point.

Applications

  • Holoenzyme reconstitution: co-incubation with recombinant CAPN1 or CAPN2 large subunit to form active calpain-1 or calpain-2 heterodimer for substrate-cleavage assays
  • Calcium-titration activity assay: measurement of calcium concentration dependence of holoenzyme activation using fluorogenic or FRET-based peptide substrates
  • Calpain inhibitor IC50 determination in reconstituted heterodimer system (e.g., calpeptin, PD150606, SNJ-1945 reference compounds)
  • Antibody validation positive control on Western blot: confirms band identity at expected molecular weight for anti-CAPNS1 detection reagents, including the matched Triple Point Biologics antibody (RP-CalpainS1)
  • Dot-blot antigen standard for titration and lot-to-lot comparison of anti-CAPNS1 antibodies
  • Substrate identification by mass spectrometry: use of reconstituted holoenzyme to digest candidate protein substrates in vitro followed by LC-MS/MS peptide mapping
  • Biophysical characterisation of EF-hand calcium binding (ITC, fluorescence spectroscopy) to study small subunit calcium affinity and conformational change

References

  1. Chen Q et al. Acute endoplasmic reticulum stress-induced mitochondria respiratory chain damage: The role of activated calpains. FASEB J. 2024. doi:10.1096/fj.202301158RR PMID: 38197290
  2. Li L et al. Calpain-mediated protein targets in cardiac mitochondria following ischemia-reperfusion. Sci Rep. 2022. doi:10.1038/s41598-021-03947-9 PMID: 34997008
  3. Mohsin AA et al. Endoplasmic reticulum stress-induced complex I defect: Central role of calcium overload. Arch Biochem Biophys. 2020. doi:10.1016/j.abb.2020.108299 PMID: 32061585
  4. Nakashima Y et al. A proteome analysis of pig pancreatic islets and exocrine tissue by liquid chromatography with tandem mass spectrometry. Islets. 2017. doi:10.1080/19382014.2017.1389826 PMID: 29099648
  5. Jian Y et al. Target and resistance-related proteins of recombinant mutant human tumor necrosis factor-related apoptosis-inducing ligand on myeloma cell lines. Biomed Rep. 2016. doi:10.3892/br.2016.650 PMID: 27284413

Additional Specifications

Storage Buffer 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol
Endotoxin Level <0.1 EU/µg by LAL
Purity (%) >90% by SDS-PAGE
Expression System HEK293
Subcellular Localization Cytoplasm; Ca²⁺-activated

Frequently Asked Questions

What molecular weight band should I expect for Calpain S-1 (Recombinant) on SDS-PAGE or Western blot?

Recombinant CAPNS1 (UniProt P04632) runs at approximately 28 kDa on reducing SDS-PAGE, consistent with its 268-amino-acid sequence (calculated MW ~28.3 kDa). Due to post-translational modifications acquired during HEK293 expression, the apparent band may shift slightly to 29–30 kDa on Western blot. Purity is >95% by SDS-PAGE under our standard QC conditions. A single predominant band at this position confirms protein integrity; a faint higher-MW band occasionally reflects residual SDS-resistant dimers, which is not indicative of degradation.

Is this recombinant the full-length CAPNS1 small subunit or a truncated fragment — does it include the penta-EF-hand domain?

This product is full-length human CAPNS1 (residues 1–268, UniProt P04632), expressed in HEK293 cells to preserve mammalian folding. It includes both the N-terminal glycine-rich domain V and the full penta-EF-hand domain required for calcium-dependent membrane association and holoenzyme stability. This matters functionally: truncations that remove even one EF-hand loop can impair calcium coordination and destabilize the heterodimer. For reconstitution experiments, full-length CAPNS1 is required to obtain a protease-competent calpain-1 or calpain-2 complex with the corresponding large subunit.

How do I reconstitute active calpain heterodimer in vitro using recombinant Calpain S-1?

Mix recombinant CAPNS1 with recombinant CAPN1 or CAPN2 large subunit in a 1:1 to 1.2:1 molar ratio in assembly buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM DTT, 1 mM EDTA) on ice for 30 minutes. Confirm complex formation by native PAGE or size-exclusion chromatography before proceeding to activity assays. Initiate proteolysis by supplementing with CaCl2 to 0.05–0.5 mM (calpain-1/µ-calpain) or 0.3–1 mM (calpain-2/m-calpain). Avoid adding calcium during assembly, as premature activation can cause autolysis of the large subunit prior to heterodimerization.

What substrate and assay buffer should I use to measure calpain activity after reconstituting with recombinant CAPNS1?

For fluorogenic activity assays, use Suc-LLVY-AMC (25–100 µM) or the calpain-specific substrate Z-Leu-Arg-AMC in assay buffer: 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM DTT, and 0.5 mM CaCl2 for calpain-1 reconstituted complexes. Read fluorescence at Ex/Em 355/460 nm. A casein zymography assay (0.1% casein in native PAGE) is a useful orthogonal confirmation. Include 10 µM ALLN (calpain inhibitor I) as a negative control to confirm calcium-dependent, calpain-specific activity rather than contaminating protease activity.

What starting concentration of recombinant Calpain S-1 should I use in an inhibitor screening or IC50 assay?

For inhibitor screening, reconstitute the CAPNS1/CAPN1 heterodimer at 10–50 nM total complex in assay buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM DTT, 0.5 mM CaCl2). Pre-incubate the complex with inhibitor for 15–30 minutes at 25°C before initiating the reaction with substrate. Confirm that substrate concentration is well below Km to avoid competitive artifact. At 50 nM heterodimer with 50 µM Suc-LLVY-AMC, linear progress curves typically extend 20–40 minutes, providing a reliable window for IC50 determination. Titrate enzyme concentration empirically for each substrate lot.

Can I use Calpain S-1 (Recombinant) as a positive control for Western blot with TPB antibody RP-CalpainS1?

Yes — this is one of the primary intended uses. REC-CalpainS1 was produced in the same lab that raised anti-calpain S-1 rabbit polyclonal antibody RP-CalpainS1, and compatibility is guaranteed. Load 20–50 ng of REC-CalpainS1 per lane alongside your cell lysate samples, run under reducing SDS-PAGE, and expect a clean band at ~28–30 kDa with RP-CalpainS1 at a 1:500–1:2000 dilution. This protein control simultaneously validates antibody sensitivity and confirms band identity in your experimental lanes, particularly important when working with complex lysates where CAPNS1 signal may be obscured.

How much recombinant Calpain S-1 should I load for Western blot positive control, and will it interfere with my lysate lanes?

Load 20–50 ng of REC-CalpainS1 in a dedicated lane separate from your cell or tissue lysate lanes to avoid any interference. At 50 ng, the RP-CalpainS1 antibody (SKU: RP-CalpainS1) reliably detects a single band at ~28–30 kDa with minimal background on PVDF or nitrocellulose. If you are titrating antibody concentration, 20 ng is sufficient at the higher end (1:500). Avoid loading more than 100 ng, as band broadening at high protein load can complicate MW estimation relative to your endogenous CAPNS1 signal in adjacent lysate lanes.

How should I store Calpain S-1 (Recombinant) and what is its shelf life after thawing?

Store at –20°C in single-use aliquots in the supplied buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol). Avoid repeated freeze-thaw cycles, which degrade EF-hand domain integrity and reduce calcium-binding efficiency. Once thawed, keep on ice and use within 4–8 hours; do not refreeze. Shelf life at –20°C is 12 months from date of receipt when stored correctly. If you require diluted working stocks (e.g., for assay plate setup), prepare them fresh in assay-compatible buffer with 0.1% BSA as carrier and use same-day. Do not store working dilutions overnight.

Validation imagery coming soon

Western blot validation figures for REC-CalpainS1 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →